While different activated forms of this receptor are prevalent in several cancers (glioma, lung cancer, breast cancer) and have been demonstrated to drive cellular transformation along with elevated TF, factor VII and other elements of the coagulome in cancer cell lines (59), these linkages are more complex in other models and, especially, in vivo (6). The gene discussed is TF; the disease is cancer.